| 000 -LEADER |
|---|
| fixed length control field |
00681nam a22002297a 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20220106110823.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
211227b ||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9783527329946 |
| 041 ## - LANGUAGE |
|---|
| Language of text/sound track |
English |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| DDC Edition number |
23 |
| Classification number |
615.19 |
| Author Mark |
PHA |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Pharmaceutical biotechnology |
| Remainder of title |
: drug discovery and clinical applications |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
2nd ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Weinheim: |
| Name of publisher, distributor, etc. |
Wiley-Blackwell; |
| Date of publication, distribution, etc. |
2012 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xxvii, 647 p. |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Includes reference and index. |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| 9 (RLIN) |
13083 |
| Topical term or geographic name entry element |
Pharmaceutical technology |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| 9 (RLIN) |
122214 |
| Topical term or geographic name entry element |
Pharmaceutical biotechnology |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| 9 (RLIN) |
122204 |
| Personal name |
Kayser, Oliver |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| 9 (RLIN) |
122208 |
| Personal name |
Warzecha, Heribert |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| item type |
Books in Reference (R) |
